drugset / Trial / NCT02003365
Study to Characterize the Local Duration of Exposure From FX006 in Patients With Osteoarthritis of the Knee
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study was to characterize the local duration of exposure of TCA for 2 doses of FX006 relative to 40 mg of TCA IR in patients with OA of the knee.
Timeline
- Start
- 2013-11
- Primary completion
- 2014-04
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tafamidis | Unknown | 10 mg | Other |
| Subject | Tafamidis | Unknown | 40 mg | Other |
| Comparator | Triamcinolone Acetonide | Other / unclassified | 40 mg | Other |